close

Fundraisings and IPOs

1 72 73 74 75 76 77
Number of results: 1535
Date Company Amount Funding type Investors Therapeutic area Type of Information
2011-05-17 Curetis (Germany) € 24.5 million series A venture equity investment round aeris Capital - LSP Life Sciences Partners (The Netherlands) - BioMedInvest (Switzerland) - KfW (Germany) - CD-Venture (Germany) - Private investors Technology - Services - Infectious diseases Fundraising
2011-05-13 Advicenne Pharma (France) €5.1 million venture capital Innobio (France) - IXO Private Equity (France) - Private investors CNS diseases - Renal diseases Fundraising
2011-05-12 Midatech (UK) £6.3 Million (€7.6 million) private investment round Cancer - Oncology Fundraising
2011-05-11 Axelar (Sweden) SEK 123 milion (€ 13.7 million) financing round syndicate of investors including Karolinska Development (Sweden) Cancer - Oncology Fundraising
2011-05-10 Stermergie Biotechnology (Switzerland) CHF 1.8 million (€1.3 million) private investors Cancer - Oncology Fundraising
2011-05-06 Opsona Therapeutics (Ireland) €5.9 million grant European Commission’s Seventh Framework Program (FP7) Transplantation Grant
2011-05-05 Selvita (Poland) PLN 14,85 million ($ 5.5 million - € 3.74 million) private placement Cancer - Oncology Private placement
2011-05-03 MdxHealth (Belgium) $ 1.1 million (€ 0.74 million) grant EuroTransBio (European Commission initiative to foster cross border research & development between companies and academia working in the biotech industry) (EU) Cancer - Oncology Grant
2011-05-03 Delenex Therapeutics (Switzerland) CHF 30.2 million (€23.5 million) Series A venture equity investment round Novo Ventures (Denmark) - SV Life Sciences (UK - USA) - HBM BioCapital (Cayman Islands) - HBM BioVentures (Cayman Islands) - BioMedInvest (Switzerland) - VI Partners (Switzerland) CNS diseases - Dermatological diseases - Inflammatory diseases Fundraising
2011-05-03 ProFibrix (The Netherlands ) €15 million ($22 million) series B follow-on financing and government credit Vesalius Biocapital (Luxembourg) - INKEF Capital Regenerative medicine - Hemostasis Fundraising
2011-04-27 Multiplicom (Belgium) € 2.0 million Series A funding round Gimv (Belgium) VIB (Belgium) University of Antwerp (Belgium) Cancer - Oncology - Genetic diseases Fundraising
2011-04-19 Curetis (Germany) € 0.5 million grant Federal Ministry of Economics and Technology (Germany) Infectious diseases Grant
2011-04-19 Circassia (UK) £60 million (€66.8 million) financing round Imperial Innovations (UK) Invesco Perpetual (UK) Allergic diseases - Inflammatory diseases - Respiratory diseases Fundraising
2011-04-19 Circassia (UK) £60 Million (€67 million - $98 Million) fundraising Imperial Innovations (UK) - other existing shareholders, including Invesco Perpetual Allergic diseases - Inflammatory diseases - Respiratory diseases Fundraising
2011-04-14 ArcticZymes (Norway) MNOK 7.2 (€ 0.9 million) grant Research Council of Norway Technology - Services Grant
2011-04-14 Vironova (Sweden) €1,72 million grant European Eurostars Programme (EU) Infectious diseases Grant
2011-04-13 mondoBIOTECH (Switzerland) CHF 8 million (€ 6.2 million) share capital increase shareholders Rare diseases Capital increase
2011-04-12 AB Science (France) € 7,539,400 bond loan agreement shareholders Cancer - Oncology - Neurodegenerative diseases Establishment of a new subsidiary in the EU
2011-04-12 Adenovir Pharma (Sweden) SEK 10.7 million (€ 1.17 million) rights issue BWG Holding - P.U.L.S. AB (Sweden) - Länsförsäkringar Skåne (Sweden) - Sparbanksstiftelsen Skånes Riskkapitalstiftelse (Sweden) - Augmenta Infectious diseases - Ophtalmological diseases Private placement
2011-04-11 Scil Proteins (Germany) €700K grant Investitionsbank Sachsen Anhalt (Germany) Cancer - Oncology Grant